Company intelligence / Profile preview

Micromole

Ownership: Private
Development stage: Preclinical

Overview

Micromole is an early-stage, multidisciplinary hard-tech company operating in stealth mode. It aims to develop foundational technologies intended to address unmet needs across biotechnology, life sciences, and pharmaceutical sectors. Specific details about clinical results or product candidates are not publicly available at this time.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Micromole.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Micromole.

Explore the full profile